Hyperprogressive disease: a distinct effect of immunotherapy?

J Thorac Dis. 2019 Mar;11(Suppl 3):S262-S265. doi: 10.21037/jtd.2019.01.97.

Authors

Vinita Popat¹, David E Gerber^{2

3

4}

Affiliations

¹ School of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
² Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
³ Department of Clinical Sciences UT Southwestern Medical Center, Dallas, Texas, USA.
⁴ Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.

No abstract available

Publication types

Editorial
Comment

Grants and funding

K24 CA201543/CA/NCI NIH HHS/United States